Discovery of Novel Imidazo[4,5-<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis-Reference-Cited by-同舟云学术

Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis

Published:2022-09-02 Issue:18 Volume:65 Page:11949-11969
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liang Xuewu¹²^ORCID,Xie Yongle¹²,Liu Xuyi¹²,Xu Hui¹²,Ren Hairu³,Tang Shuai¹²,Liu Qi¹²,Huang Min¹²,Shao Xueqing¹²,Li Chunpu¹²,Zhou Yu¹²^ORCID,Geng Meiyu¹²,Xie Zuoquan¹²,Liu Hong¹²³^ORCID

Affiliation:

1. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai201203, China

2. University of Chinese Academy of Sciences, Beijing100049, China

3. School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou310024, China

Funder

Shanghai Municipal Health and Family Planning Commission

National Natural Science Foundation of China

Lingang Laboratory

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00390

Reference43 articles.

1. Inflammatory bowel disease: cause and immunobiology